ストックスクリーナーアプリを入手
62.84
2.33%
-1.50
前日終値:
$64.34
開ける：
$64.66
24時間の取引高:
1.73M
Relative Volume:
0.72
時価総額：
$9.57B
収益：
$3.46B
当期純損益:
$-9.40M
株価収益率:
-261.40
EPS:
-0.2404
ネットキャッシュフロー:
$51.30M
1週間 パフォーマンス:
+3.95%
1か月 パフォーマンス:
+4.42%
6か月 パフォーマンス:
+41.88%
1年 パフォーマンス:
+63.52%
1日の値動き範囲:
$61.25
$65.30
1週間の範囲:
$59.05
$65.30
52週間の値動き範囲:
$28.53
$65.30
Bruker Corp Stock (BRKR) Company Profile
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
62.84 | 9.14B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 開始されました | Goldman | Sell |
| 2025-11-20 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Eversept Partners LP Reduces Stock Position in Bruker Corporation $BRKR - MarketBeat
Bank of New York Mellon Corp Decreases Stake in Bruker Corporation $BRKR - MarketBeat
Bruker Market Sentiment - Benzinga
Bruker Corp (BRKR) Cash Flow - TradingKey
Bruker Corp (BRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
First Trust Advisors LP Has $53.93 Million Holdings in Bruker Corporation $BRKR - MarketBeat
BRKR|Bruker Corp|Price:60.680|Chg%:+0.230 - TradingKey
Bruker Corporation $BRKR Shares Sold by Lombard Odier Asset Management Europe Ltd - MarketBeat
London Co. of Virginia Has $93.34 Million Stock Holdings in Bruker Corporation $BRKR - MarketBeat
Bruker Corp (BRKR) Income Statement - TradingKey
Bruker Corp (BRKR) Balance Sheet - TradingKey
BRKR|Bruker Corp|Price:60.450|Chg%:-1.700 - TradingKey
Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bruker’s Q2 earnings call starts Aug. 4 at 9 a.m. ET - Stock Titan
Press Release: Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast - Moomoo
A Look at Bruker Corp (BRKR) After 4.0% Gain -- GF Value $62.85 vs Price $62.15 - GuruFocus
Bruker Corp (BRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bruker Corporation (BRKR) Stock Forecasts - Yahoo Finance
Bruker Corp (MIL:1BRKR) Stock Price, Trades & News - GuruFocus
Bruker (NASDAQ:BRKR) Trading 7.7% HigherShould You Buy? - MarketBeat
Is Bruker Corp (BRKR) a Bargain After 3.5% Drop? GF Value Says U - GuruFocus
Bruker Corp | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Bruker Corp (BRKR) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Bastion Asset Management Inc. Acquires Shares of 21,471 Bruker Corporation $BRKR - MarketBeat
Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern - MSN
Bruker Corp exec Mark Munch sells $120,500 in shares By Investing.com - Investing.com Nigeria
Bruker Corp exec Mark Munch sells $120,500 in shares - Investing.com
Form 4 Bruker Corporation For: 16 July By Investing.com - Investing.com Canada
Bruker Corp (NASDAQ: BRKR) EVP Munch sells 2,000 shares under 10b5-1 plan - Stock Titan
Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Raises Target Price to $40 - Moomoo
BRKR (NASDAQ: BRKR) holder plans July 2026 sale of 2,000 shares - Stock Titan
Bruker (BRKR) Acquires DISQVER Metagenomics Platform - GuruFocus
Bruker acquires clinical metagenomics platform from Noscendo - Investing.com
Press Release: Bruker Expands Infection Detection Portfolio With Acquisition of Metagenomic MNGS DISQVER(R) Platform for Pathogenic Microorganisms in Blood - Moomoo
Bruker's Research-Only Platform Analyzes Blood in Under 24 Hours - Stock Titan
Frank Laukien - Forbes
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood - Yahoo Finance
Guggenheim reiterates Bruker stock Buy rating on metrology demand - Investing.com
Bruker Corporation $BRKR Shares Bought by Candriam S.C.A. - MarketBeat
Bruker Corp (BRKR) executive Wolfgang Pusch discloses 10,154 Common Stock shares - Stock Titan
Bruker Corp (BRKR) Shares Surge 5.9% -- What GF Score of 86 Tells Investors - GuruFocus
Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60 - Moomoo
Bruker Corp strengthens its position in advanced scientific instruments as investors watch long-term - Ad-hoc-news.de
Leerink Partners Forecasts Strong Price Appreciation for Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker Corporation $BRKR Shares Sold by SG Americas Securities LLC - MarketBeat
Leerink raises Bruker stock price target to $70 on semiconductor strength - Investing.com Nigeria
Bruker Corp highlights advanced scientific instruments as investors watch the stock - AD HOC NEWS
Bruker (NASDAQ:BRKR) Sparks Fresh Lab Tech Buzz - Kalkine Media
Bruker (NASDAQ:BRKR) Clears A Key Market Test - Kalkine Media
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $70 - Moomoo
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
Bruker Corp (BRKR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Jul 15 '26 |
Sale |
60.25 |
2,000 |
120,500 |
128,443 |
1.04%
11.95%
大文字化:
|
ボリューム (24 時間):